Utah Lung Cancer Advocate Travels to Washington, D.C. to Ask Congress for Increased Research Funding

Jan Poulsen will join volunteers from across the nation to ask members of Congress to take action against lung cancer

Utah resident and lung cancer advocate Jan Poulsen will travel to Washington, D.C. to meet with her members of Congress during the American Lung Association’s LUNG FORCE Advocacy Day on March 29. As part of the nationwide event, Poulsen will join more than 40 other people across the country who have been impacted by lung cancer to ask lawmakers to support $51 billion in research funding for the National Institutes of Health (NIH), $11.6 billion in funding for the Centers for Disease Control and Prevention (CDC) and to support and protect Medicaid.

Poulsen was diagnosed with lung cancer in 2007. With family history but no other clear risk factors for the disease, she was searching for answers when she learned about radon gas—a naturally occurring, odorless, radioactive gas that is common in Utah. After enduring the removal of her right lung, months of treatments, and even brain surgery in 2014, she uses her story to help raise awareness about radon and advocate for other Utahns affected by lung cancer.

“Years after remodeling our basement, we discovered that the radon levels in our home were more than six times the recommended action level,” said Poulsen. “I want everyone to know – if it can happen to me, it can happen to you.”

During Advocacy Day, Poulsen will speak with the offices of Senators Mitt Romney and Mike Lee and Representative John Curtis to share her personal experience with lung cancer and explain why investments in public health, research funding and quality and affordable healthcare are important to her.

The Lung Association launched LUNG FORCE Advocacy Day in 2016 to ask members of Congress to support robust, sustainable and predictable federal funding increases for lung cancer research, prevention and quality and affordable healthcare.

As a part of Advocacy Day, LUNG FORCE Heroes have succeeded in helping increase NIH lung cancer research funding by over 115%. Since 2016, more than 50 new therapies have been approved by the FDA to treat lung cancer—giving more hope to those impacted by this disease. In 2022, Heroes successfully urged Congress to extend funding for tax credits so more than three million Americans were able to keep affordable healthcare coverage through the federal and state marketplaces.

Poulsen encourages others in Utah to advocate for lung cancer research and healthcare protections by contacting their members of Congress, which they can do at Lung.org/AdvocacyDay. Learn more about Poulsen’s story and the LUNG FORCE initiative at LUNGFORCE.org.

For more information, contact:

Gregg Tubbs
(202) 715-3469
[email protected]

Clinical Trials: Why It's Important to Participate
, | Dec 14, 2023